MRI in Rectal Cancer. Kartik S Jhaveri, MD,FRCPC Director, Abdominal MRI Director, CME Program

Size: px
Start display at page:

Download "MRI in Rectal Cancer. Kartik S Jhaveri, MD,FRCPC Director, Abdominal MRI Director, CME Program"

Transcription

1 MRI in Rectal Cancer Kartik S Jhaveri, MD,FRCPC Director, Abdominal MRI Director, CME Program

2 DISCLOSURES No Relevant Disclosures 2

3 OBJECTIVES Imaging of Rectal Cancer Why MRI? MR Protocol MR Anatomy Preoperative Staging/Treatment Planning Special Considerations: Low Rectal Cancer 3 Post CRT MRI Evaluation

4 BACKGROUND Colorectal Cancers are the Second most common cause for cancer related deaths Local pelvic recurrence after surgical resection is a major concern Usually leads to Incurable disease and poor QOL Reduce pelvic recurrence - Increase disease free survival Primary goal of Staging is to triage treatment 4

5 STAGING - IMAGING ERUS LOCAL MRI METASTASES CT/PET-CT 5

6 ERUS VS MRI S T T1 VS T2 T2 VS T3 ERUS MRI < > ERUS M A T3 VS T4 MRI >ERUS R G E N MRI >ERUS I M CT/PET-CT 6

7 ERUS VS MRI S T T1 VS T2 T2 VS T3 ERUS MRI < > ERUS M A T3 VS T4 MRI >ERUS R G E N MRI >ERUS I M CT/PET-CT 7

8 ERUS VS MRI S T T1 VS T2 T2 VS T3 ERUS MRI < > ERUS M A T3 VS T4 MRI >ERUS R G E N MRI >ERUS I M CT/PET-CT 8

9 ERUS VS MRI S T T1 VS T2 T2 VS T3 ERUS MRI < > ERUS M A T3 VS T4 MRI >ERUS R G E N MRI >ERUS I M CT/PET-CT 9

10 ERUS VS MRI ERUS Bulky or Stenotic tumors Very High or Very Low Mass Mesorectal Fascia LN detection outside mesorectum Post neoadjuvant response evaluation? MRI MRI is also performed without Endoluminal device insertion 10

11 MRI RECTUM PROTOCOL TORSO PA MUTLICHANNEL COIL Diffusion Weighted Imaging-DWI 1.5T / 3T MRI System T2 SAG,COR,AX HI RES OBLIQUE T2 3D T2? Multiphasic Gd- Enhanced Series 11

12 MR PARAMETERS-1.5T Sequence Slice(mm) Matrix Time(min) FOV(mm) LOCS T1 AXIAL GRE 5/1 256 X T2 FSE SAG 4/1 320 x T2 FSE COR 4/1 320 x T2 FSE AXIAL 4/1 320 x T2 HI RES OBLIQUE 3/0 320 x T2 SPACE/FRFSE 1 x 1 x x DWI-b0,50,400,1000 4/1 128 x T1 SAG/AX Gd 3D VIBE/LAVA 4/0 320 x x

13 Hi Res Angled T2 MR High-resolution 3mm slice thickness Matrix > 256 x 256/320 x320 Perpendicular to the tumoral axes 13

14 Hi Res Angled T2 MR High-Quality MRI Is A Fundamental Requirement To Obtain Accurate Anatomical Information Of The Tumoral Relationships 14

15 Hi Res Angled T2 MR High-Quality MRI is a fundamental requirement to obtain accurate anatomical information of the tumoral relationships 15

16 DWI Post CRT Evaluation Tumor recurrence LN,Tumor visualization T2 DWI GAD 16

17 CONTRAST Rectal? Intravenous? 17 Endoluminal Contrast DYNAMIC RUN Tumor Detection Post CRT LN Characterization

18 18 ANATOMY

19 T2 CORONAL Levator ani Int Sphincter Puborectalis Ext Sphincter 19 NORMAL MRI ANATOMY

20 T2 SAGITAL 20 Tumor Localization Anal Verge Adjacent Organs- Vagina,Prostate,SV Anterior Peritoneal reflection

21 T2 AXIAL Muscularis Propria Submucosa 21

22 T2 AXIAL 22 MESORECTAL FASCIA

23 MESORECTUM SUGICAL IMPLICATIONS: TOTAL MESORECTAL EXCISION (TME) Mesorectal Fascia = Excisional Margin in TME 23 = Circumferential Resection Margin(CRM)

24 Peritoneal Reflection AXIAL T2 24 Peritoneum attaches in a V shaped manner onto the anterior surface of upper rectum Seagull Sign

25 Peritoneal Reflection Sagittal T2 Denonvilliers Rectovaginal Fascia 25

26 Role of MRI :Rectal Cancer Preoperative Staging & Treatment Stratification Post Neoadjuvant Therapy Tumor Recurrence Evaluation 26

27 Preoperative Staging Positive Surgical Margin = Recurrence Neg. Surgical Margin = Curative Resection Margins at Risk = Neoadjuvant ChemoRad Rectal MR Identify At risk / Positive margins Prognostic features. Treatment Stratification - Surgery vs Preop CRT 27

28 28 SYNOPTIC MR REPORTING

29 Preoperative Staging -TUMOR LOCALIZATION & SPHINCTERS - -EXTRAMURAL SPREAD (T STAGE) -CIRCUMFERENTIAL RESECTION MARGIN (CRM) -PERITONEAL REFLECTION -EXTRAMURAL VASCULAR INVASION (EMVI) -LYMPH NODES-N 29 -METASTASIS-M (Bones)

30 TUMOR LOCALIZATION & SPHINCTERS 30 LOW 0-5cm, MID 5-10cm, UPPER 10-15cm

31 31 SPHINCTERS

32 T Stage T1 invades sub-mucosa T2 invasion of circular/longitudinal layers T3 invasion through muscularis T4 direct invasion of other organs or visceral peritoneum 32

33 33 T1/T2

34 34 T2

35 35 T3

36 DEPTH OF EXTRAMURAL INVASION (T3) Depth 5-yr Survival *AJCC (2010)* <5mm 85% >5mm 54% T3a <5mm T3b 5-10mm T3c >10mm EXTENSIVE EXTRAMURAL SPREAD POOR PROGNOSIS 36

37 37 T2/T3

38 T3 Desmoplastic Reaction vs T3 38

39 39 Circumferential Resection Margin -CRM

40 Circumferential Resection Margin (CRM) CIRCUMFERENTIAL RESECTION MARGIN (CRM) CIRCUMFERENTIAL? 40

41 Visceral Peritoneum and CRM Courtersy Dr. Mahmoud Khalifa, Dept of Pathology,Toronto 41

42 CRM and MRI MRI : >5mm from CRM Pathology >1-2mm Negative Margin MERCURY TRIAL MRI >1mm from CRM= Neg.Margin 42

43 CRM 43 CRM >5mm CRM = 0 mm

44 44 CRM & Satellite Tumoral Nodule

45 45 Peritoneal Reflection

46 EXTRAMURAL VASCULAR INVASION (EMVI) Discrete Serpiginous or Tubular Intermediate Signal Projections in Mesorectal fat MRI Sens 62% - Spec 88% 46

47 T4 47 Mucinous Tumor- Poor CRT response

48 LOW RECTAL CANCER Adenoca in 0-5cm from anal verge High Positive CRM rates Permanent Stoma Anal Ca(SCC) is NOT Rectal cancer(adenoca) 48

49 LOW (ANO)RECTAL CANCER Relation to Anorectal Junction Adv.T2 49 T3

50 LOW (ANO)RECTAL CANCER T4 50

51 LOW (ANO)RECTAL CANCER Courtesy Dr. Fayez Qureshy,Colorectal Surgery, UHN 51

52 N STAGE N0: No regional lymph node metastasis N1: Metastases in 1 to 3 nearby lymph nodes N2: Metastases in 4 or more nearby lymph nodes N3 : Distant LN Rectum : External &Common iliac and abdominal 52

53 LYMPH NODES Accuracy of Different Techniques Test Sens Spec ERUS CT/(PET) 55 74/(~80) MRI Bipat et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MRI a meta-analysis.. Radiology, 2004; 232:

54 Criteria Of Nodal Metastasis Size criteria >8mm (round) > 10mm (oval) Morphologic criteria Irregular Contour and Hetergoneous signal Brown G et al. Morphologic predictors of lymph node status in rectal cancer with use of highspatial-resolution MRI with histopathologic comparison. Radiology 2003; 227:

55 DWI Increased Detection of <1cm Nodes Differentiation of Benign vs Malignant? - Not Reliable 55

56 Lateral Pelvic Nodes PREOP CRT NO PRE/POST CRT = LATERAL PELVIC RECURRENCE 56

57 MRI Accuracy T Staging : % N Staging : % CRM : 95 % MRI is more accurate in predicting free resection margin than T stage!!! Beets-Tan RG et al. Lancet 2001 Brown G et al. BJS 2003 & RSNA 2004 Nagtegaal I et al. Am J Surg Path

58 MRI PITFALLS IN T STAGE T1 VS T2 T3 DESMOPLASTIC REACTION- OVERSTAGING CRM -Thin Patients - Anterior wall tumor - Lower rectal tumor NODES- Normal sized nodes 58

59 POST CRT EVALUATION Direct Surgical Approach after preop neoadjuvant therapy without repeat MR? ~ 80% Respond (~10-20% complete) Major Pelvic Surgery Hi PostOp Morbitiy(40-50%) Why Post CRT MRI? -Assess Tumor Response -Reassess Tumor Resectabiity Threat to Margin? -Personalize Surgery based on Response 59 Wait & Watch vs TME vs APR?

60 TUMOR REGRESSION GRADING AJCC Tumor Regression Grade (Pathology) Description Tumor Regression Grade No viable cancer cells TRG 0 (Complete response) Single cells or small groups of cancer cells TRG 1 (Near complete response) Residual cancer outgrown by fibrosis TRG 2 (Partial response) Minimal to no tumor kill TRG 3 (No response) MRI No tumor signal mrtrg 1 Predominant Fibrosis(minimal tumor) mrtrg 2 Mixed fibrosis and tumor mrtrg 3 Predominant Tumor mrtrg 4 Tumor(little fibrosis) mrtrg 5 60 Patel U et al. AJR:199, October 2012

61 POST CRT EVALUATION :MRI T stage ~50% (T2WI) ; DWI (improves accuracy) T2 MR Volumetry - Good TRG correlation NPV for CRM : 98% Overall CRM ~77% mrtrg : Predictive of CRM involvement Nodes ~72% Memon S et al.colorectal Dis Apr 61

62 POST NEOADJUVANT EVALN mrtrg4/5 - NO RESPONSE / PROGESSION 62

63 POST NEOADJUVANT EVALN mrtrg1 (NEAR COMPLETE RESPONSE) 63

64 SUMMARY Endorectal US for T1 VS T2 MRI ( ERUS) FOR Stage T3 and Higher High Quality MRI Critical -Hi Res Angled Images MRI most accurate for CRM Synoptic Reporting and MDT Meetings 64

Neoadjuvant therapy are we doing it right? Short course and chemoradiation

Neoadjuvant therapy are we doing it right? Short course and chemoradiation Neoadjuvant therapy are we doing it right? Short course and chemoradiation Rob Glynne-Jones Mount Vernon Cancer Centre Relevant Endpoints in rectal cancer Local recurrence Disease-free survival Overall

More information

The evolution of rectal cancer therapy. Objectives

The evolution of rectal cancer therapy. Objectives The evolution of rectal cancer therapy Hagen Kennecke MD MHA FRCPC Western Canada Consensus Conference September 5, 2014 Objectives Identify standard therapy: stage II/III rectal cancer Update recent adjuvant

More information

Rectal Cancer. To Radiate or not to radiate? Q: Should rectal cancer RT/CRT decisions be based solely on stage? 11/09/2014

Rectal Cancer. To Radiate or not to radiate? Q: Should rectal cancer RT/CRT decisions be based solely on stage? 11/09/2014 Rectal Cancer To Radiate or not to radiate?? Dr. Corinne Doll Radiation Oncologist Tom Baker Cancer Centre Calgary, Alberta Q: Should rectal cancer RT/CRT decisions be based solely on stage? 1 Q: Can RT/CRT

More information

Approccio multidisciplinare nei tumori del retto

Approccio multidisciplinare nei tumori del retto Approccio multidisciplinare nei tumori del retto F. Muñoz Radiation Oncology Department University of Torino, Italy RECENT CHANGES IN RECTAL CANCER DIAGNOSIS AND THERAPY Optimal staging by EUS and MRI

More information

The Staging of Colorectal Cancer: What s New in the Seventh Edition of The AJCC Cancer Staging Manual

The Staging of Colorectal Cancer: What s New in the Seventh Edition of The AJCC Cancer Staging Manual The Staging of Colorectal Cancer: What s New in the Seventh Edition of The AJCC Cancer Staging Manual J. Milburn Jessup, MD Chief, Diagnostics Evaluation Branch Cancer Diagnosis Program, DCTD National

More information

Image. 3.11.3 SW Review the anatomy of the EAC and how this plays a role in the spread of tumors.

Image. 3.11.3 SW Review the anatomy of the EAC and how this plays a role in the spread of tumors. Neoplasms of the Ear and Lateral Skull Base Image 3.11.1 SW What are the three most common neoplasms of the auricle? 3.11.2 SW What are the four most common neoplasms of the external auditory canal (EAC)

More information

EMR Can anyone do this?

EMR Can anyone do this? EMR Can anyone do this? Norio Fukami, MD University of Colorado Piecemeal resection? 1 Endoscopic mucosal resection (EMR) and Endoscopic submucosal dissection (ESD) Endoscopic removal of premalignant or

More information

A912: Kidney, Renal cell carcinoma

A912: Kidney, Renal cell carcinoma A912: Kidney, Renal cell carcinoma General facts of kidney cancer Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type

More information

Bridging Techniques. What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS

Bridging Techniques. What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS Bridging Techniques What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS Associate Professor of Surgery Assistant Program Director, General Surgery Residency Disclosures

More information

User s Guide for the Synoptic MRI Report for Rectal Cancer

User s Guide for the Synoptic MRI Report for Rectal Cancer User s Guide for the Synoptic MRI Report for Rectal Cancer INSTRUCTIONS This User s Guide accompanies the synoptic MRI report and provides a rationale and detailed explanation of how to report each item

More information

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background

Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the

More information

Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy

Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy W. Fraser Symmans, M.D. Associate Professor of Pathology UT M.D. Anderson Cancer Center Pathologic Complete Response (pcr) Proof

More information

Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate e P rofessor Professor Radiation Oncology

Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate e P rofessor Professor Radiation Oncology Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate Professor Radiation Oncology Disclosure Information I have no financial relationships to disclose relevant to the conten of this presentation.

More information

Stadards in Abdominoperineal Resection

Stadards in Abdominoperineal Resection Stadards in Abdominoperineal Resection Manuel Francisco T. Roxas, MD, FPCS, FPSCRS, FACS Clinical Associate Professor, University of the Philippines Chief, Section of Colorectal Surgery, Department of

More information

GENERAL SUMMARY AND DISCUSSION

GENERAL SUMMARY AND DISCUSSION GENERAL SUMMARY AND DISCUSSION In the last 30 years, abdominal surgery has progressed from the standard open approach to less invasive techniques such as laparoscopy and natural orifice translumenal endoscopic

More information

National Program of Cancer Registries Education and Training Series. How to Collect High Quality Cancer Surveillance Data

National Program of Cancer Registries Education and Training Series. How to Collect High Quality Cancer Surveillance Data National Program of Cancer Registries Education and Training Series How to Collect High Quality Cancer Surveillance Data 1 NAACCR Administers NPCR-Education Contract for the Centers for Disease Control

More information

Pathological assessment of the rectal cancer resection specimen

Pathological assessment of the rectal cancer resection specimen P R A C T I C E G U I D E L I N E S Pathological assessment of the rectal cancer resection specimen Authors Key words A. Hoorens, M. De Ridder, A. Jouret-Mourin, C. Sempoux, C.A. Cuvelier, N. Nagy, G.

More information

Kidney Cancer OVERVIEW

Kidney Cancer OVERVIEW Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney

More information

CHAPTER 14 STAGING AND REPORTING

CHAPTER 14 STAGING AND REPORTING CHAPTER 14 STAGING AND REPORTING Staging of Colorectal Cancer refers to the classification of the tumour according to the extent of spread in a manner that has a clinically useful correlation with prognosis.

More information

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD

SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:

More information

Approach to Cut Up Large Intestine. Prof Geraint Williams Wales College of Medicine Cardiff University

Approach to Cut Up Large Intestine. Prof Geraint Williams Wales College of Medicine Cardiff University Approach to Cut Up Large Intestine Prof Geraint Williams Wales College of Medicine Cardiff University Inflammatory Conditions Neoplasia Resection Specimens Polyps and Local Resections Before You Start

More information

Individual Prediction

Individual Prediction Individual Prediction Michael W. Kattan, Ph.D. Professor of Medicine, Epidemiology and Biostatistics, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Chairman, Department

More information

A918: Prostate: adenocarcinoma

A918: Prostate: adenocarcinoma A918: Prostate: adenocarcinoma General facts of prostate cancer The prostate is about the size of a walnut. It is just below the bladder and in front of the rectum. The tube that carries urine (the urethra)

More information

Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy

Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy Sarah Hutto,, MSIV Marc Underhill, M.D. January 27, 2009 Past History 45 yo female

More information

Current Status and Perspectives of Radiation Therapy for Breast Cancer

Current Status and Perspectives of Radiation Therapy for Breast Cancer Breast Cancer Current Status and Perspectives of Radiation Therapy for Breast Cancer JMAJ 45(10): 434 439, 2002 Masahiro HIRAOKA, Masaki KOKUBO, Chikako YAMAMOTO and Michihide MITSUMORI Department of Therapeutic

More information

OBJECTIVES By the end of this segment, the community participant will be able to:

OBJECTIVES By the end of this segment, the community participant will be able to: Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway

More information

PROTOCOL OF THE RITA DATA QUALITY STUDY

PROTOCOL OF THE RITA DATA QUALITY STUDY PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of

More information

How To Compare The Effects Of A Hysterectomy And A Hysterectomy

How To Compare The Effects Of A Hysterectomy And A Hysterectomy A RANDOMIZED TRIAL COMPARING RADICAL HYSTERECTOMY AND PELVIC NODE DISSECTION VS SIMPLE HYSTERECTOMY AND PELVIC NODE DISSECTION IN PATIENTS WITH LOW RISK EARLY STAGE CERVICAL CANCER A Gynecologic Cancer

More information

Cancer of the Cardia/GE Junction: Surgical Options

Cancer of the Cardia/GE Junction: Surgical Options Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD

More information

National Bowel Cancer Audit Report 2008 Public and Executive Summary

National Bowel Cancer Audit Report 2008 Public and Executive Summary National Bowel Cancer Audit Report 2008 Public and Executive Summary Prepared in association with: Healthcare Quality Improvement Partnership HQIP Association of Coloproctology of Great Britain and Ireland

More information

Colorectal Cancer Treatment

Colorectal Cancer Treatment Scan for mobile link. Colorectal Cancer Treatment Colorectal cancer overview Colorectal cancer, also called large bowel cancer, is the term used to describe malignant tumors found in the colon and rectum.

More information

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER Prospective Mesothelioma Staging Project Data Forms and Fields in CRAB Electronic Data Capture System - Reduced Set - Pivotal data elements for developing

More information

Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson

Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson The following relevant disclosures, conflicts of interest and/ or financial relationships exist related to this presentation: Consultant

More information

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012

Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro. Joon H. Lee 9/17/2012 Extrapleural Pneumonectomy for Malignant Mesothelioma: Pro Joon H. Lee 9/17/2012 Malignant Pleural Mesothelioma (Epidemiology) Incidence: 7/mil (Japan) to 40/mil (Australia) Attributed secondary to asbestos

More information

Case Report: Whole-body Oncologic Imaging with syngo TimCT

Case Report: Whole-body Oncologic Imaging with syngo TimCT Case Report: Whole-body Oncologic Imaging with syngo TimCT Eric Hatfield, M.D. 1 ; Agus Priatna, Ph.D. 2 ; John Kotyk, Ph.D. 1 ; Benjamin Tan, M.D. 1 ; Alto Stemmer 3 ; Stephan Kannengiesser, Ph.D. 3 ;

More information

Challenges in gastric, appendiceal and rectal NETs Leuven, 29.11.2014

Challenges in gastric, appendiceal and rectal NETs Leuven, 29.11.2014 Challenges in gastric, appendiceal and rectal NETs Leuven, 29.11.2014 Prof. Dr. Chris Verslype, Leuven Prof. Dr. Aurel Perren, Bern Menue Challenges: 1. Gastric NET 2. Appendiceal NET 3. Rectal NET SEER,

More information

Sentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds

Sentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds Sentinel Lymph Node Mapping for Endometrial Cancer Locke Uppendahl, MD Grand Rounds Endometrial Cancer Most common gynecologic malignancy in US estimated 52,630 new cases in 2014 estimated 8,590 deaths

More information

Recommendations for cross-sectional imaging in cancer management, Second edition

Recommendations for cross-sectional imaging in cancer management, Second edition www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Breast cancer Faculty of Clinical Radiology www.rcr.ac.uk Contents Breast cancer 2 Clinical background 2 Who

More information

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER

GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT

More information

Chapter 5. Eur J Cancer 2009; 45: 1175-1183

Chapter 5. Eur J Cancer 2009; 45: 1175-1183 Chapter 5 The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer Marcel

More information

Chapter 2 Staging of Breast Cancer

Chapter 2 Staging of Breast Cancer Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination

More information

Frequently Asked Questions About Ovarian Cancer

Frequently Asked Questions About Ovarian Cancer Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues

More information

How to report Upper GI EMR/ESD specimens

How to report Upper GI EMR/ESD specimens Section of Pathology and Tumour Biology How to report Upper GI EMR/ESD specimens Dr.H.Grabsch Warning. Most of the criteria, methodologies, evidence presented in this talk are based on studies in early

More information

PET/CT in Lung Cancer

PET/CT in Lung Cancer PET/CT in Lung Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria GLOBOCAN 2012 #1 #3 FDG-PET/CT

More information

Lesions, and Masses, and Tumors Oh My!!

Lesions, and Masses, and Tumors Oh My!! Lesions, and Masses, and Tumors Oh My!! Presented by: Susan Ward, CPC, CPC-H, CPC-I, CPCD, CEMC, CPRC 1 1 CPT GUIDELINES Agenda CPT DEFINITIONS OP REPORT CASES 2 Definitions Cyst - a closed sac having

More information

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH 9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH Differentiated thyroid cancer expresses the TSH receptor on the cell membrane and responds to TSH stimulation by increasing

More information

Update on Mesothelioma

Update on Mesothelioma November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical

More information

Newly Diagnosed Prostate Cancer: Understanding Your Risk

Newly Diagnosed Prostate Cancer: Understanding Your Risk Newly Diagnosed Prostate Cancer: Understanding Your Risk When the urologist calls with the life-changing news that your prostate biopsy is positive for prostate cancer, an office appointment is made to

More information

CT and MRI features of the Pathologic Subtypes of Papillary Renal Cell Carcinoma. Melissa Price, MD Aoife Kilcoyne, MD Mukesh G.

CT and MRI features of the Pathologic Subtypes of Papillary Renal Cell Carcinoma. Melissa Price, MD Aoife Kilcoyne, MD Mukesh G. CT and MRI features of the Pathologic Subtypes of Papillary Renal Cell Carcinoma Melissa Price, MD Aoife Kilcoyne, MD Mukesh G. Harisinghani, MD Disclosures Neither I nor my immediate family members have

More information

MR Imaging of Peritoneal Malignancy Russell N. Low, MD

MR Imaging of Peritoneal Malignancy Russell N. Low, MD MR Imaging of Peritoneal Malignancy Russell N. Low, MD From: Sharp and Children's MRI Center and Sharp HealthCare, 7901 Frost Street, San Diego, California, 92123. Phone: (858) 939-3600. Email: rlow@ucsd.edu

More information

How common is bowel cancer?

How common is bowel cancer? information Primary Care Society for Gastroenterology Bowel Cancer (1 of 6) How common is bowel cancer? Each year 35,000 people in Britain are diagnosed with cancer of the bowel, that is to say cancer

More information

Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases.

Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Abstract This paper describes the staging, imaging, treatment, and prognosis of renal cell carcinoma. Three case studies

More information

Recurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve,

Recurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve, Recurrent & Persistent Papillary Thyroid Cancer Central Nodal Dissection vs. Node-Picking Patterns of Nodal Metastases Recurrent Laryngeal Nerve, Larynx, Trachea, & Esophageal Management Robert C. Wang,

More information

Assessment of T staging and mesorectal fascia status using high-resolution MRI in rectal cancer with rectal distention

Assessment of T staging and mesorectal fascia status using high-resolution MRI in rectal cancer with rectal distention Online Submissions: wjg.wjgnet.com World J Gastroenterol 2007 August 14; 13(30): 4141-4146 World Journal of Gastroenterology ISSN 1007-9327 wjg@wjgnet.com 2007 WJG. All rights reserved. RAPID COMMUNICAION

More information

Moving Beyond RECIST

Moving Beyond RECIST Moving Beyond RECIST Ihab R. Kamel, M.D., Ph.D. ikamel@jhmi.edu Associate Professor Clinical Director, MRI Department of Radiology The Johns Hopkins University School of Medicine Outline Standard measures

More information

A Practical Guide to Advances in Staging and Treatment of NSCLC

A Practical Guide to Advances in Staging and Treatment of NSCLC A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging

More information

Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer

Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer David Josephson, MD FACS Fellowship Director, Urologic Oncology and Robotic Surgery Program Staging Most important in risk assessment and

More information

These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.

These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma. Prostate Cancer OVERVIEW Prostate cancer is the second most common cancer diagnosed among American men, accounting for nearly 200,000 new cancer cases in the United States each year. Greater than 65% of

More information

The outcome of rectal cancer after early salvage surgery following transanal endoscopic microsurgery seems promising

The outcome of rectal cancer after early salvage surgery following transanal endoscopic microsurgery seems promising The outcome of rectal cancer after early salvage surgery following transanal endoscopic microsurgery seems promising Katarina Levic, Orhan Bulut, Peter Hesselfeldt & Steffen Bülow ABSTRACT INTRODUCTION:

More information

Overview of Gynaecologic Cancer

Overview of Gynaecologic Cancer Overview of Gynaecologic Cancer Stuart Salfinger Gynaecologic Oncologist St John of God Hospital King Edward Memorial Hospital Cervical Cancer Cervical Cancer Risk HPV Smoking?OCP Cervical Cancer Symptoms

More information

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History

More information

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical

Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical Summary. 111 Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical recurrence (BCR) is the first sign of recurrent

More information

Colorectal Cancer in Norway

Colorectal Cancer in Norway Colorectal Cancer in Norway National Treatment Guidelines and Outcomes Bjørn Steinar Olden Nedrebø Dissertation for the degree philosophiae doctor (PhD) at the University of Bergen Stavanger 2013 Dissertation

More information

LCA Colorectal Cancer Clinical Guidelines

LCA Colorectal Cancer Clinical Guidelines LCA Colorectal Cancer Clinical Guidelines September 2014 1 LCA COLORECTAL CANCER CLINICAL GUIDELINES Contents Introduction... 6 Executive Summary... 8 1 Early Diagnosis and Screening of Colorectal Cancer...

More information

DIAGNOSIS OF PROSTATE CANCER

DIAGNOSIS OF PROSTATE CANCER DIAGNOSIS OF PROSTATE CANCER Determining the presence of prostate cancer generally involves a series of tests and exams. Before starting the testing process, the physician will ask questions about the

More information

Staging Head and Neck Cancers Transitioning to the Seventh Edition of The AJCC Cancer Staging Manual

Staging Head and Neck Cancers Transitioning to the Seventh Edition of The AJCC Cancer Staging Manual Staging Head and Neck Cancers Transitioning to the Seventh Edition of The AJCC Cancer Staging Manual Jatin P. Shah, MD, PhD (Hon) Memorial Sloan-Kettering Cancer Center New York, New York The American

More information

In Practice Whole Body MR for Visualizing Metastatic Prostate Cancer

In Practice Whole Body MR for Visualizing Metastatic Prostate Cancer In Practice Whole Body MR for Visualizing Metastatic Prostate Cancer Prostate cancer is the second most common cancer in men worldwide, accounting for 15% of all new cancer cases. 1 Great strides have

More information

Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD

Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD KCHC 8/29/13 52 y.o. F presented with severe pain in the right back and right flank, sharp, 8 out of 10, for 7 days.

More information

MRI of the Uterus BENIGN. Jeffrey C. Weinreb, M.D. FACR jeffrey.weinreb@yale.edu Yale University School of Medicine

MRI of the Uterus BENIGN. Jeffrey C. Weinreb, M.D. FACR jeffrey.weinreb@yale.edu Yale University School of Medicine MRI of the Uterus BENIGN Jeffrey C. Weinreb, M.D. FACR jeffrey.weinreb@yale.edu Yale University School of Medicine Normal Anatomy M Junctional JZ Zone EE Junctional Zone is the inner layer or the myometrium

More information

Cervical Cancer The Importance of Cervical Screening and Vaccination

Cervical Cancer The Importance of Cervical Screening and Vaccination Cervical Cancer The Importance of Cervical Screening and Vaccination Cancer Cells Cancer begins in cells, the building blocks that make up tissues. Tissues make up the organs of the body. Sometimes, this

More information

Colon Cancer vs. Rectal Cancer: What is the Difference? Webcast March 31, 2010 Karen Horvath, M.D., F.A.C.S. Introduction

Colon Cancer vs. Rectal Cancer: What is the Difference? Webcast March 31, 2010 Karen Horvath, M.D., F.A.C.S. Introduction Colon Cancer vs. Rectal Cancer: What is the Difference? Webcast March 31, 2010 Karen Horvath, M.D., F.A.C.S. Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle

More information

Secondary Cancer and Relapse Rates Following Radical Prostatectomy for Prostate-Confined Cancer

Secondary Cancer and Relapse Rates Following Radical Prostatectomy for Prostate-Confined Cancer Copyright E 2007 Journal of Insurance Medicine J Insur Med 2007;39:242 250 MORTALITY Secondary Cancer and Relapse Rates Following Radical Prostatectomy for Prostate-Confined Cancer David Wesley, MD; Hugh

More information

Directly Coded Summary Stage Is Back

Directly Coded Summary Stage Is Back Directly Coded Summary Stage Is Back Donna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry June 30, 2015 1 Outline What is SEER Summary Stage 2000 (SS2000)? Summary Stage Housekeeping

More information

Elective Clinical Target Volumes in Anorectal Cancer: An RTOG Consensus Panel Contouring Atlas

Elective Clinical Target Volumes in Anorectal Cancer: An RTOG Consensus Panel Contouring Atlas Elective Clinical Target Volumes in Anorectal Cancer: An RTOG Consensus Panel Contouring Atlas 1 2 1 3 1 1 4 R Myerson, M Garofalo, Iel Naqa, R Abrams, A Apte, W Bosch, P Das, L 5 6 7 8 9 Gunderson, T

More information

Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study

Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study Original Article Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study Sezer Saglam 1, Dursun Bugra 2, Esra K. Saglam 3, Oktar Asoglu 4, Emre

More information

Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer

Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer PRACTICE GUIDELINE Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer Scott R. Steele, M.D. George J. Chang, M.D., M.S. Samantha Hendren, M.D. Marty

More information

What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer? Iris D. Nagtegaal and Phil Quirke

What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer? Iris D. Nagtegaal and Phil Quirke VOLUME 26 NUMBER 2 JANUARY 10 2008 JOURNAL OF CLINICAL ONCOLOGY R E V I E W A R T I C L E What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer? Iris D. Nagtegaal and

More information

Target Volumes for Anal Carcinoma For RTOG 0529

Target Volumes for Anal Carcinoma For RTOG 0529 Target Volumes for Anal Carcinoma For RTOG 0529 Robert Myerson, M.D. Ph.D.*, Lisa Kachnic, M.D.**, Jacqueline Esthappan, Ph.D.*,Parag Parikh M.D.*William Straube M.S.*, John Willins, Ph.D.** *Washington

More information

Diagnosis of Recurrent Prostate Tumor at Multiparametric Prostate MRI: Pearls and Pitfalls

Diagnosis of Recurrent Prostate Tumor at Multiparametric Prostate MRI: Pearls and Pitfalls Diagnosis of Recurrent Prostate Tumor at Multiparametric Prostate MRI: Pearls and Pitfalls Mark Notley, MD; Jinxing Yu, MD; Ann S. Fulcher, MD; Mary A. Turner, MD; Don Nguyen, MD Virginia Commonwealth

More information

Report series: General cancer information

Report series: General cancer information Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for

More information

Tumor Budding as a Useful Prognostic Marker in T1-Stage Squamous Cell Carcinoma of the Esophagus

Tumor Budding as a Useful Prognostic Marker in T1-Stage Squamous Cell Carcinoma of the Esophagus 2013;108:42 46 Tumor Budding as a Useful Prognostic Marker in T1-Stage Squamous Cell Carcinoma of the Esophagus HITOSHI TERAMOTO, MD, 1 * MASAHIKO KOIKE, MD, PhD, 1 CHIE TANAKA, MD, PhD, 1 SUGURU YAMADA,

More information

CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014

CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014 Background CMScript Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014 Prostate cancer is second only to lung cancer as the leading cause of cancer-related deaths in men. It is

More information

Carcinoma rettale: ruolo della radioterapia

Carcinoma rettale: ruolo della radioterapia Carcinoma rettale: ruolo della radioterapia M.A.Gambacorta Cattedra di Radioterapia Università Cattolica del Sacro Cuore-Roma Is radiotherapy active? D 10 7 Gy Primary tumour Cells 10 10-12 Positive Nodes

More information

Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.

Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer. Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which

More information

PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY. Dr. Shailesh V. Shrikhande

PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY. Dr. Shailesh V. Shrikhande PANCREATIC AND PERIAMPULLARY TUMORS: PANCREATICODUODENECTOMY Dr. Shailesh V. Shrikhande Associate Professor & Consultant Surgeon GI and HPB Surgical Oncology Tata Memorial Hospital, Mumbai INDIA HELICAL

More information

DEFINING A NEW ERA IN DIGESTIVE DISEASE INTERVENTIONS

DEFINING A NEW ERA IN DIGESTIVE DISEASE INTERVENTIONS DEFINING A NEW ERA IN DIGESTIVE DISEASE INTERVENTIONS JEAN-CLAUDE HORIOT MD RADIO-ONCOLOGIST CLINIQUE DE GENOLIER, GSMN JACQUES BERNIER MD, PD RADIO-ONCOLOGIST CLINIQUE DE GENOLIER, GSMN 01.05.2015 2 THE

More information

NEURO MRI PROTOCOLS TABLE OF CONTENTS

NEURO MRI PROTOCOLS TABLE OF CONTENTS TABLE OF CONTENTS NEURO MRI PROTOCOLS BRAIN...2 Brain 1 Screen... 2 Brain 2 Brain Tumor... 2 Brain 3 Brain Infection / Meningitis... 2 Brain 4 Trauma... 3 Brain 5 Hemorrhage... 3 Brain 6 Demyelinating

More information

Standards and datasets for reporting cancers. Dataset for colorectal cancer histopathology reports. July 2014

Standards and datasets for reporting cancers. Dataset for colorectal cancer histopathology reports. July 2014 Standards and datasets for reporting cancers Dataset for colorectal cancer histopathology reports July 2014 Authors: Dr Maurice B Loughrey, Consultant Pathologist, Royal Victoria Hospital, Belfast Trust,

More information

UICC World Cancer Congress. Cancer Staging and Quality of Care

UICC World Cancer Congress. Cancer Staging and Quality of Care UICC World Cancer Congress August 27 30, 2012, Montreal CANCER STAGE: A neglected cornerstone of Cancer Control Cancer Staging and Quality of Care Christian Wittekind Institut für Pathologie UKL 1 Agenda!

More information

Change in bowel habit-is it

Change in bowel habit-is it Change in bowel habit-is it irritable bowel? Mr PJ Arumugam MS, FRCS (Edin-Gen Surg), PGCE Consultant Colorectal Surgeon Royal Cornwall Hospital & Duchy Hospital, Truro, UK Objectives Irritable bowel syndrome-

More information

7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Melanoma of Skin. Overview. This webinar is sponsored by

7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Melanoma of Skin. Overview. This webinar is sponsored by AJCC 7 th Edition Staging Melanoma of Skin Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers

More information

Therapies for Prostate Cancer and Treatment Selection

Therapies for Prostate Cancer and Treatment Selection Prostatic Diseases Therapies for Prostate Cancer and Treatment Selection JMAJ 47(12): 555 560, 2004 Yoichi ARAI Professor and Chairman, Department of Urology, Tohoku University Graduate School of Medicine

More information

How To Treat A Uterine Sarcoma

How To Treat A Uterine Sarcoma EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas

More information

Medullary Renal Cell Carcinoma Case Report

Medullary Renal Cell Carcinoma Case Report Bahrain Medical Bulletin, Vol. 27, No. 4, December 2005 Medullary Renal Cell Carcinoma Case Report Mohammed Abdulla Al-Tantawi MBBCH, CABS* Abdul Amir Issa MBBCH, CABS*** Mohammed Abdulla MBBCH, CABS**

More information

Together, The Strength

Together, The Strength DECATUR County Indiana Together, The Strength to Fight Cancer Barbara Taylor, MD Cancer Committee Chairperson Rahul Dewan, DO Radiation Oncology Cancer Liasion Jaime Ayon, MD Medical Oncology/ Hematology

More information

Early Prostate Cancer: Questions and Answers. Key Points

Early Prostate Cancer: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:

More information

False positive PET in lymphoma

False positive PET in lymphoma False positive PET in lymphoma Thomas Krause Introduction and conclusion 2 3 Introduction 4 FDG-PET in staging of lymphoma 34 studies with 2227 Patients CT FDG-PET Sensitivity 63 % 89 % (58%-100%) (63%-100%)

More information

CANCER PULMON: ESTADIOS INICIALES POSTMUNDIAL PULMON DENVER 2015. 8-10-2015.Manuel Cobo Dols S. Oncología Médica HU Málaga Regional y VV

CANCER PULMON: ESTADIOS INICIALES POSTMUNDIAL PULMON DENVER 2015. 8-10-2015.Manuel Cobo Dols S. Oncología Médica HU Málaga Regional y VV CANCER PULMON: ESTADIOS INICIALES POSTMUNDIAL PULMON DENVER 2015 8-10-2015.Manuel Cobo Dols S. Oncología Médica HU Málaga Regional y VV Meta-analisis LACE: adyuvancia vs no adyuvancia Pignon JP, et al.

More information

Peritoneal Surface Malignancies. Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA

Peritoneal Surface Malignancies. Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA Peritoneal Surface Malignancies Ira Allen Jacobs, MD, FACS Surgical Oncology San Diego, CA Cancer dissemination routes Hematogenous metastases Lymphatic metastases Implants on peritoneal surfaces Surgically

More information

J Clin Oncol 28:264-271. 2009 by American Society of Clinical Oncology INTRODUCTION

J Clin Oncol 28:264-271. 2009 by American Society of Clinical Oncology INTRODUCTION VOLUME 28 NUMBER 2 JANUARY 1 21 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data Leonard L. Gunderson, John Milburn

More information